Press Releases

2013-06-19

Athera and Boehringer Ingelheim enter into an option agreement on a novel therapy for Atherosclerosis
2013-06-17

EU grants EUR 6m to the clinical development of Athera´s cardiovascular disease antibody therapy
2013-05-23

First patient dosed in the Phase I/II study of Umecrine Mood’s candidate drug for premenstrual dysphoric disorder
2013-05-15

Karolinska Development´s Annual General Meeting 2013
2013-05-10

Karolinska Development AB (publ) - Interim report January - March 2013
2013-05-07

Karolinska Development - Interim report January - March, invitation to conference call Friday, May 10
2013-04-19

Pergamum announces last visit of last patient in a Phase I/II trial of a potential new treatment for hard-to-heal wounds
2013-04-12

Karolinska Development’s Annual Report 2012 has been published
2013-04-12

Notice of Annual General Meeting of Karolinska Development AB (publ)
2013-04-10

Bo Jesper Hansen proposed as new Chairman of the Board
2013-04-02

Preliminary results of a Phase II study indicates that Axelar’s AXL1717 is efficacious in 2nd line treatment of patients with lung cancer
2013-03-08

Karolinska Development and Rosetta Capital Announce the Closing of their SEK 220 Million Strategic Transaction
2013-02-20

Karolinska Development AB (publ) – Year-End Report 2012
2013-02-18

Karolinska Development – Year-End Report 2012, invitation to conference call and webcast Wednesday, February 20
2013-02-08

Pergamum AB announces a strategic collaboration with Cadila Pharmaceuticals Ltd
2013-02-04

Karolinska Development signs agreement with Mayo Clinic
2013-01-30

Dilaforette – Phase II study with sevuparin for the treatment of severe malaria initiated